Procaps Group S.A. (PROC)
NASDAQ: PROC · Real-Time Price · USD
0.572
+0.043 (8.03%)
Nov 20, 2024, 4:00 PM EST - Market closed
Procaps Group Market Cap
Procaps Group has a market cap or net worth of $64.48 million as of November 21, 2024. Its market cap has decreased by -77.68% in one year.
Market Cap
64.48M
Enterprise Value
335.91M
1-Year Change
-77.68%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since December 9, 2019, Procaps Group's market cap has decreased from $239.85M to $64.48M, a decrease of -73.12%. That is a compound annual growth rate of -23.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 59.68M | -87.00% |
| Dec 29, 2023 | 459.19M | -22.48% |
| Dec 30, 2022 | 592.33M | -46.15% |
| Dec 31, 2021 | 1.10B | 323.09% |
| Dec 31, 2020 | 260.00M | 8.29% |
| Dec 31, 2019 | 240.09M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 65.63M |
| Hyperfine | 65.36M |
| AlloVir | 65.16M |
| Spero Therapeutics | 64.86M |
| Celularity | 64.70M |
| electroCore | 64.08M |
| ALX Oncology Holdings | 63.82M |
| Forian | 63.76M |